New study challenges the traditional view of gene switches

Some sequences in the genome cause genes to be switched on or off. Until now, each of these gene switches, or so-called enhancers, was thought to have its own place on the DNA.

atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates | Psychedelic Invest

NEW YORK and BERLIN, May 15, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of

May 15, 2024

Study links improved dietary fat quality to reduced cardiovascular and diabetes risk

The impact of dietary fat quality on lipid metabolites and its association with reduced cardiometabolic disease risk.

July 15, 2024

AbCellera, Regeneron expand antibody discovery collaboration

The collaboration utilises AbCellera’s antibody discovery engine and Regeneron’s VelocImmune mice to detect novel therapeutic antibodies. Credit: angellodeco/Shutterstock.com. AbCellera and Regeneron have extended their current

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.